APA (7th ed.) Citation

Santos, H. S., Poletto, E., Vera, L. N. P., Farinon, M., Kubaski, F., Carneiro, P. B., . . . Baldo, G. (2026). Liposomal CRISPR/Cas9-Mediated Local Genome Editing for Joint Disease in Mucopolysaccharidosis Type I. Pharmaceutics, 18(3), 281. https://doi.org/10.3390/pharmaceutics18030281

Chicago Style (17th ed.) Citation

Santos, Hallana Souza, et al. "Liposomal CRISPR/Cas9-Mediated Local Genome Editing for Joint Disease in Mucopolysaccharidosis Type I." Pharmaceutics 18, no. 3 (2026): 281. https://doi.org/10.3390/pharmaceutics18030281.

MLA (9th ed.) Citation

Santos, Hallana Souza, et al. "Liposomal CRISPR/Cas9-Mediated Local Genome Editing for Joint Disease in Mucopolysaccharidosis Type I." Pharmaceutics, vol. 18, no. 3, 2026, p. 281, https://doi.org/10.3390/pharmaceutics18030281.